Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule investigational drug |
| gptkbp:ATCCode |
none (not assigned)
|
| gptkbp:CASNumber |
1001264-89-6
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:developedBy |
gptkb:Genentech
gptkb:Roche |
| gptkbp:hasMolecularFormula |
C24H28ClN5O3S
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ipatasertib
|
| gptkbp:indication |
gptkb:cancer
prostate cancer solid tumors |
| gptkbp:mechanismOfAction |
AKT inhibitor
|
| gptkbp:molecularWeight |
501.03 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2105727
25154816 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea fatigue rash hyperglycemia |
| gptkbp:status |
investigational
|
| gptkbp:synonym |
gptkb:GDC-0068
gptkb:RG7440 |
| gptkbp:target |
gptkb:AKT1
gptkb:AKT2 gptkb:AKT3 |
| gptkbp:UNII |
6Z1Y2V4S2E
|
| gptkbp:bfsParent |
gptkb:AKT
|
| gptkbp:bfsLayer |
6
|